Literature DB >> 30877179

Dual-Time-Point 18F-Fluorocholine PET/CT in Parathyroid Imaging.

Wouter A M Broos1, Maurits Wondergem2, Friso M van der Zant2, Remco J J Knol2.   

Abstract

18F-fluorocholine (18F-FCH) PET/CT is a promising and increasingly used scan technique in the preoperative imaging of parathyroid adenoma. Several acquisition methods have been evaluated in the literature, but the optimal image acquisition time point after administration of the tracer is still under debate.
Methods: Patients who had hyperparathyroidism, underwent dual-time-point 18F-FCH PET/CT (image acquisition, 5 min; 60 min after injection), and had histologically proven pathologic parathyroid glands were retrospectively included in the study. Early and late images were compared both visually and quantitatively.
Results: Sixty-four patients were included, and a total of 71 parathyroid glands were surgically removed. Visually, there were no differences between early and late images of hyperfunctioning parathyroid glands in 44 patients (69%); in 13 patients (20%), visualization on early images was better; in 6 patients (9%), visualization of hyperfunctioning glands was best on late images; and in 1 patient (2%), the lesion was exclusively visualized on late images. For the total cohort, there was a significant decrease in 18F-FCH uptake in the glands on late versus early time points (P = 0.001), but there was a significant increase in the ratio of parathyroid uptake to thyroid uptake (P = 0.037). The group of patients with better visualization on early images showed a decrease over time in both parathyroid uptake and the ratio of parathyroid uptake to thyroid uptake, significant in comparison to those in both the group with better visualization at later time points and the group in which visualization was similar at both time points (P values of 0.000-0.018). There were no significant differences in 18F-FCH uptake and the ratio of parathyroid uptake to thyroid uptake between the latter 2 groups (P values of 0.200-0.709).
Conclusion: In most patients (89%), hyperfunctioning parathyroid glands were adequately visualized on early imaging; however, in a subset of patients (11%), such glands were best visualized at later time points. Therefore, we recommend the acquisition of dual-time-point images in parathyroid imaging with 18F-FCH PET/CT or the creation of an opportunity to acquire additional late images after review of early images when findings are inconclusive.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-fluorocholine; PET/CT; dual time point; hyperparathyroidism; parathyroid adenoma

Year:  2019        PMID: 30877179     DOI: 10.2967/jnumed.118.225599

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

Review 1.  Diagnostic Value of Choline PET in the Preoperative Localization of Hyperfunctioning Parathyroid Gland(s): A Comprehensive Overview.

Authors:  Cristina Ferrari; Giulia Santo; Paolo Mammucci; Antonio Rosario Pisani; Angela Sardaro; Giuseppe Rubini
Journal:  Biomedicines       Date:  2021-02-25

2.  Thyroid 18F-fluorocholine uptake in patients with chronic autoimmune thyroiditis.

Authors:  Renaud Ciappuccini; Virginie Saguet-Rysanek; Marine Dorbeau; Justine Lequesne; Camille Linard; Sophie Lefevre-Arbogast; Bénédicte Clarisse; Stéphane Bardet
Journal:  Eur Thyroid J       Date:  2022-06-21

Review 3.  Will 18F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging?

Authors:  Luca Giovanella; Lorenzo Bacigalupo; Giorgio Treglia; Arnoldo Piccardo
Journal:  Endocrine       Date:  2020-09-06       Impact factor: 3.633

4.  18F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism.

Authors:  Valentin Pretet; Marianela Rotania; Mehdi Helali; Mihaela Ignat; Michel Vix; Alessio Imperiale
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

Review 5.  Parathyroid Imaging: Past, Present, and Future.

Authors:  Michael A Morris; Babak Saboury; Mark Ahlman; Ashkan A Malayeri; Elizabeth C Jones; Clara C Chen; Corina Millo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-25       Impact factor: 5.555

Review 6.  Is there a consensus between clinical practice guidelines for conventional and molecular nuclear medicine studies in parathyroid pathology?

Authors:  Marylin Acuña Hernandez; Liset Sanchez Orduz; Uvi Cancino Ramos; Paola Vallejo Armenta; Leonardo Cadavid Blanco
Journal:  Ann Nucl Med       Date:  2021-07-24       Impact factor: 2.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.